[HTML][HTML] Circulating tumor cells in colorectal cancer: Detection systems and clinical utility

J Petrik, D Verbanac, M Fabijanec… - International journal of …, 2022 - mdpi.com
Colorectal cancer (CRC) is the third most common cancer worldwide. The high mortality
from CRC is mainly related to metastasis affecting distant organs and their function …

[HTML][HTML] Ibero-American Consensus Review and Incorporation of New Biomarkers for Clinical Practice in Colorectal Cancer

CE Bonilla, P Montenegro, JM O'Connor… - Cancers, 2023 - mdpi.com
Simple Summary The management of colorectal cancer has improved significantly due to
advances in molecular techniques. Thanks to these techniques, it has been possible to …

[HTML][HTML] CD26 deficiency controls macrophage polarization markers and signal transducers during colitis development and resolution

I Vukelic, S Buljevic, L Baticic, K Barisic… - International journal of …, 2022 - mdpi.com
Ulcerative colitis (UC) is a multifactorial condition characterized by a destructive immune
response that failed to be attenuated by common regulatory mechanisms which reduce …

[HTML][HTML] Small extracellular vesicles: key forces mediating the development and metastasis of colorectal cancer

W Zhang, X Hu, Z Jiang - Cells, 2022 - mdpi.com
Colorectal cancer (CRC) is the third most common cancer worldwide, and its incidence and
mortality rates have been increasing annually in recent years. A variety of different small …

[PDF][PDF] Ibero-American Consensus Review and Incorporation of New Biomarkers for Clinical Practice in Colorectal Cancer. Cancers 2023, 15, 4373

CE Bonilla, P Montenegro, JM O'Connor… - 2023 - researchgate.net
Advances in genomic technologies have significantly improved the management of
colorectal cancer (CRC). Several biomarkers have been identified in CRC that enable …

[PDF][PDF] Ibero-American Consensus Review and Incorporation of New Biomarkers for Clinical Practice in Colorectal Cancer. Cancers 2023, 15, 0

CE Bonilla, P Montenegro, JM O'Connor… - 2023 - institutoroffo.uba.ar
Advances in genomic technologies have significantly improved the management of
colorectal cancer (CRC). Several biomarkers have been identified in CRC that enable …

Caracterización epigenética de la heterogeneidad intratumoral espacial y temporal. comparativa entre tumor primario y metástasis hepáticas de cáncer colorectal

JL Manzano Mozo - 2022 - ddd.uab.cat
Introducció: Durant el procés de carcinogènesi del CCR, hi ha una acumulació progressiva
d'alteracions genètiques i epigenètiques a la transició teixit normal-adenoma …

The bioinformatics and experimental analysis of CD276 for prognosis and immune infiltrates in colon adenocarcinoma

R Chen, C Chai, S Ma, Q Guan, D Wu - 2022 - researchsquare.com
Background Colon adenocarcinoma (COAD), although the third-most common type of
gastrointestinal tumors, still lacks specific biomarkers for early diagnosis, treatment, and …